UPDATE : Monday, September 7, 2020
상단여백
Korea’s share remains small in multinational pharmaceuticals’ operation by Marian Chu and Nam Doo-hyun 2017-05-09 02:53
Can Jardiance threaten Forxiga's dominance in treating diabetes? by Park Gi-taek 2017-05-04 13:30
‘Korean drug market to grow twice faster than GDP until 2021’ by Lee Hye-seon 2017-05-02 14:33
FDA okays first drug for Batten disease by Constance Williams 2017-04-28 15:49
JW Pharmaceutical worst of 10 major drugmakers for women to work in by Nam Doo-hyun 2017-04-28 12:07
라인
FDA approves 1st treatment for liver cancer in decade by Constance Williams 2017-04-28 11:25
Boryung’s 1Q sales hit ₩99.8 billion by Lee Hye-seon 2017-04-27 14:59
How Daewoong released Korea’s 1st generic drug in US? by Lee Hye-seon 2017-04-27 13:28
Expectations rise about new bio drug going global by Lee Hye-seon 2017-04-26 18:06
Customized subfertility therapy to debut in Korea by Lee Hye-seon 2017-04-26 16:22
라인
FDA warns 14 firms against selling false cancer-curing products by Constance Williams 2017-04-26 10:49
Samsung Bioepis wins first FDA approval for biosimilar drug by Marian Chu 2017-04-24 18:18
Pharmacists oppose introduction of corporate-style drugstores by Constance Williams 2017-04-21 16:51
Baxter allegedly forces workers to quit under disguise of advice by Marian Chu 2017-04-20 16:17
Daewoong launches first generic antibiotic in US by Constance Williams 2017-04-19 18:03
라인
State auditors ‘fail to confirm Hanmi’s cover-up of clinical results’ by Marian Chu 2017-04-18 15:23
FDA stuns Eli-Lilly, Incyte by rejecting rheumatoid arthritis drug by Constance Williams 2017-04-17 17:17
Cancer patients protest against Novartis Korea by Marian Chu 2017-04-17 15:04
Korean firms stage ‘let’s-save-our drug’ drive by Lee Hye-seon 2017-04-14 15:30
Hanmi preempts global incontinence drug market by Lee Hye-seon 2017-04-12 18:37
여백
여백
여백
Back to Top